Translations:Benfotiamine/2/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
14,944 edits
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 09:19, 3 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Benfotiamine)
'''Benfotiamine''' ([[International Nonproprietary Name|rINN]], or '''''S''-benzoylthiamine ''O''-monophosphate''') is a synthetic, fat-soluble, ''S''-acyl derivative of [[thiamine]] (vitamin B1) that is approved in some countries as a medication or [[dietary supplement]] to treat [[diabetic neuropathy|diabetic sensorimotor polyneuropathy]]. Benfotiamine was developed in late 1950s in Japan.

Benfotiamine (rINN, or S-benzoylthiamine O-monophosphate) is a synthetic, fat-soluble, S-acyl derivative of thiamine (vitamin B1) that is approved in some countries as a medication or dietary supplement to treat diabetic sensorimotor polyneuropathy. Benfotiamine was developed in late 1950s in Japan.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Benfotiamine/2/en&oldid=133211"